|
|
||||||||
Research Article
1The University of Western Australia 2The Norwegian University of Science and Technology 3University of Western Australia
Submitted 19 December 2008 ; revised 3 August 2009 ; accepted in final form 13 October 2009
Transferrin receptor (TFR) 1 and 2 are expressed in the liver; TFR1 levels are regulated by cellular iron levels whilst TFR2 levels are regulated by transferrin saturation. The aims of this study were to (1) determine the relative importance of TFR1 and TFR2 in transferrin-bound iron (TBI) uptake by HuH7 human hepatoma cells, and (2) characterize the role of metal-transferrin complexes in the regulation of these receptors. TFR expression was altered by: [1] incubation with metal-transferrin (Tf) complexes, [2] TFR1 and TFR2 siRNA knockdown and [3] transfection with a hTFR2 plasmid. TBI uptake was measured using 59Fe-125I-Tf and mRNA and protein expression by real-time PCR and western blot analysis, respectively. Fe2Tf, Co2Tf and Mn2Tf increased TFR2 protein expression indicating the upregulation was not specifically regulated by iron-transferrin but also other metal-transferrins. Also, Co2Tf and Mn2Tf upregulated TFR1, reduced ferritin and increased hypoxia-inducible factor-1
(HIF-1
) protein expression suggesting TFR1 upregulation was due to a combination of iron deficiency and chemical hypoxia. TBI uptake correlated with changes in TFR1 but not TFR2 expression. TFR1 knockdown reduced iron uptake by 80% while TFR2 knockdown did not affect uptake. At 5µM transferrin, iron uptake was not affected by combined TFR1 and TFR2 knockdown. Transfection with a hTFR2 plasmid increased TFR2 protein expression causing a 15-20% increase in iron uptake and ferritin levels. This shows for the first time that TFR mediated TBI uptake is mediated primarily via TFR1 but not TFR2, and a high capacity TFR independent pathway exists in hepatoma cells.
TFR1; TFR2; cobalt; siRNA; chemical hypoxia
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |